|
PRKD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.504560E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.714400E-02 |
| Normal-vs-Stage2 |
1.031410E-01 |
| Normal-vs-Stage3 |
1.365040E-04 |
| Normal-vs-Stage4 |
2.23280000000159E-06 |
| Stage1-vs-Stage2 |
7.170600E-01 |
| Stage1-vs-Stage3 |
8.541300E-03 |
| Stage1-vs-Stage4 |
6.226700E-04 |
| Stage2-vs-Stage3 |
2.080800E-01 |
| Stage2-vs-Stage4 |
5.169700E-02 |
| Stage3-vs-Stage4 |
2.995600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.180100E-03 |
| Normal-vs-AfricanAmerican |
2.565600E-04 |
| Normal-vs-Asian |
9.329600E-01 |
| Caucasian-vs-AfricanAmerican |
7.340200E-02 |
| Caucasian-vs-Asian |
3.327800E-01 |
| AfricanAmerican-vs-Asian |
9.880500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.398630E-03 |
| Normal-vs-Female |
7.019000E-03 |
| Male-vs-Female |
5.568400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.910000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.836300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.987300E-04 |
| Normal-vs-Age(81-100Yrs) |
9.613900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.147600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.159600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.347600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.017900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.917800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.913650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.888400E-01 |
| Normal-vs-Grade 2 |
1.223950E-01 |
| Normal-vs-Grade 3 |
2.3819000000147E-06 |
| Normal-vs-Grade 4 |
4.32350000000303E-05 |
| Grade 1-vs-Grade 2 |
3.701200E-01 |
| Grade 1-vs-Grade 3 |
7.656200E-03 |
| Grade 1-vs-Grade 4 |
7.161600E-03 |
| Grade 2-vs-Grade 3 |
2.839500E-04 |
| Grade 2-vs-Grade 4 |
1.118420E-03 |
| Grade 3-vs-Grade 4 |
5.635000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.441760E-01 |
| Normal-vs-ccB subtype |
4.821700E-03 |
| ccA subtype-vs-ccB subtype |
4.686000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.300500E-03 |
| Normal-vs-N1 |
3.024400E-02 |
| N0-vs-N1 |
4.416800E-01 |
|
|
